dc.creator | Rodrigues | |
dc.creator | Aline Teotonio; Stahlschmidt | |
dc.creator | Rebeca; Granja | |
dc.creator | Silvia; Pilger | |
dc.creator | Diogo; Eiras Falcao | |
dc.creator | Antonio Luis; Mazzola | |
dc.creator | Priscila Gava | |
dc.date | 2017 | |
dc.date | 2017-11-13T13:43:49Z | |
dc.date | 2017-11-13T13:43:49Z | |
dc.date.accessioned | 2018-03-29T05:58:32Z | |
dc.date.available | 2018-03-29T05:58:32Z | |
dc.identifier | Brazilian Journal Of Pharmaceutical Sciences. Univ São Paulo Conjunto Quimicas, v. 53, p. , 2017. | |
dc.identifier | 1984-8250 | |
dc.identifier | 2175-9790 | |
dc.identifier | WOS:000400155300025 | |
dc.identifier | 10.1590/s2175-97902017000116109 | |
dc.identifier | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000100624&lng=en&tlng=en | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/328646 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1365671 | |
dc.description | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description | Patients in intensive care unit are prescribed large numbers of drugs, highlighting the need to study potential Drug-Drug Interactions in this environment. The aim of this study was to delineate the prevalence and risk of potential drug-drug interactions between medications administered to patients in an ICU. This cross-sectional observational study was conducted during 12 months, in an adult ICU of a teaching hospital. Inclusion criteria were: prescriptions with 2 or more drugs of patients admitted to the ICU for > 24 hours and age of >= 18 years. Potential Drug-Drug Interactions were quantified and classified through Micromedex (TM) database. The 369 prescriptions included in this study had 205 different drugs, with an average of 13.04 +/- 4.26 ( mean +/- standard deviation) drugs per prescription. Potential Drug-Drug Interactions were identified in 89% of these, with an average of 5.00 +/- 5.06 interactions per prescription. Of the 405 different pairs of potentially interacting drugs identified, moderate and major interactions were present in 74% and 67% of prescriptions, respectively. The most prevalent interaction was between dipyrone and enoxaparin (35.8%), though its clinical occurrence was not observed in this study. The number of potential Drug-Drug Interactions showed significant positive correlations with the length of stay in the intensive care unit, and with the number of prescribed drugs. Acknowledging the high potential for Drug-Drug Interactions in the ICU represents an important step toward improving patient safety and best therapy results. | |
dc.description | 53 | |
dc.description | 1 | |
dc.description | National Council of Technological and Scientific Development (CNPq. Brasilia, DF, Brazil) | |
dc.description | Sao Paulo Research Foundation (FAPESP. Sao Paulo, SP, Brazil) | |
dc.description | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.language | English | |
dc.publisher | Univ São Paulo Conjunto Quimicas | |
dc.publisher | São Paulo | |
dc.relation | Brazilian Journal of Pharmaceutical Sciences | |
dc.rights | aberto | |
dc.source | WOS | |
dc.subject | Potential Drug-drug Interactions | |
dc.subject | Intensive Care Unit | |
dc.subject | Patient Safety | |
dc.subject | University Hospitals | |
dc.title | Prevalence Of Potential Drug-drug Interactions In The Intensive Care Unit Of A Brazilian Teaching Hospital | |
dc.type | Artículos de revistas | |